1. Home
  2. PROK vs NEON Comparison

PROK vs NEON Comparison

Compare PROK & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • NEON
  • Stock Information
  • Founded
  • PROK 2015
  • NEON 1997
  • Country
  • PROK United States
  • NEON Sweden
  • Employees
  • PROK N/A
  • NEON N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • NEON Industrial Machinery/Components
  • Sector
  • PROK Health Care
  • NEON Technology
  • Exchange
  • PROK Nasdaq
  • NEON Nasdaq
  • Market Cap
  • PROK 384.2M
  • NEON 428.0M
  • IPO Year
  • PROK N/A
  • NEON 2007
  • Fundamental
  • Price
  • PROK $2.35
  • NEON $21.56
  • Analyst Decision
  • PROK Buy
  • NEON Strong Buy
  • Analyst Count
  • PROK 5
  • NEON 1
  • Target Price
  • PROK $6.25
  • NEON $16.50
  • AVG Volume (30 Days)
  • PROK 3.3M
  • NEON 271.6K
  • Earning Date
  • PROK 08-12-2025
  • NEON 08-13-2025
  • Dividend Yield
  • PROK N/A
  • NEON N/A
  • EPS Growth
  • PROK N/A
  • NEON N/A
  • EPS
  • PROK N/A
  • NEON N/A
  • Revenue
  • PROK $527,000.00
  • NEON $2,605,000.00
  • Revenue This Year
  • PROK $105.79
  • NEON N/A
  • Revenue Next Year
  • PROK N/A
  • NEON $39.01
  • P/E Ratio
  • PROK N/A
  • NEON N/A
  • Revenue Growth
  • PROK N/A
  • NEON N/A
  • 52 Week Low
  • PROK $0.46
  • NEON $2.44
  • 52 Week High
  • PROK $7.13
  • NEON $29.90
  • Technical
  • Relative Strength Index (RSI)
  • PROK 43.77
  • NEON 44.01
  • Support Level
  • PROK $2.16
  • NEON $22.05
  • Resistance Level
  • PROK $2.46
  • NEON $25.27
  • Average True Range (ATR)
  • PROK 0.34
  • NEON 2.03
  • MACD
  • PROK -0.16
  • NEON -0.40
  • Stochastic Oscillator
  • PROK 7.14
  • NEON 21.36

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

Share on Social Networks: